Thanks to the popular TV show Blacklist, America is becoming familiar with CRISPR, a revolutionary gene-editing tool. UAB scientists and students explain how it works — and how they are using these “molecular scissors” to cut a path toward genetic cures for sickle cell and brain diseases
David Kimberlin, M.D., vice chair of Pediatrics and co-director of the Division of Pediatric Infectious Diseases, is a physician at Children’s of Alabama. He is the editor of the American Academy of Pediatrics’ Red Book, which establishes which vaccines should be given, when and to whom.
Published in Faculty Excellence
For women with a prior low transverse incision cesarean delivery, the decision to undergo a vaginal delivery or elect to have a repeat cesarean delivery has important clinical and economic ramifications.
The UAB study, an updated meta-analysis of the use of implantable cardioverter-defibrillators for non-ischemic cardiomyopathy, provides further support to the current American Heart Association and American College of Cardiology guidelines and challenges the recently published DANISH trial.
Published in Focus on Patient Care
For the first time in humans, it has been reported that eating early in the day lessens daily swings in hunger and changes the 24-hour pattern of fat oxidation and energy metabolism, which may aid in weight loss.
Published in Focus on Patient Care
Pediatric patients admitted to intensive care units face increased risk of death from sudden kidney problems.
A UAB study shows that evaluation from a vision specialist should be included in return-to-learn concussion protocols.
A key Leukemia & Lymphoma Society grant will provide an opportunity for a UAB researcher to develop a new immunotherapy treatment approach for the leukemia most prevalent in Western countries.
Published in Faculty Excellence
UAB secured more than $328.5 million in federal research funding in 2015, ranking the institution No. 18 among public universities and No. 34 overall in the United States during a year in which UAB’s total research and development expenditures exceeded $516 million.
Three decades of clinical trials have changed the face of HIV/AIDS.
Published in Focus on Patient Care

Christopher S. Brown, Ph.D., former vice president of Research for the University of North Carolina System and director and primary investigator of the NASA/North Carolina Space Grant, tapped to grow UAB’s $500 million annual research portfolio.

U.S. News & World Report ranks UAB No. 162 in its 2017 Best Global Universities ranking, up from its rank of No. 200 in 2016 and 269 spots higher than the next-highest-ranked university in Alabama.
Published in Faculty Excellence

best of 2016After major investments in information technology infrastructure — bringing the fastest supercomputer in Alabama to campus — UAB can now execute tasks in a couple of hours that took an entire day just a year ago. 

Becker’s Hospital Review ranks the UAB Comprehensive Cancer Center as one of 100 Hospitals and Health Systems with great oncology programs in America. 

Published in Service to Community

A significant new UAB study published in Cancer shows that key socioeconomic factors, not race, affect survival of younger multiple myeloma patients.   

Published in Focus on Patient Care

With 12 associates, the UAB Health System Cancer Community Network integrates patients, collaboration and community to change the way cancer care is delivered in the region. 

Published in Focus on Patient Care

Sowing the Seeds of Health, a longstanding educational program at the UAB Comprehensive Cancer Center, helps to reduce breast and cervical cancer among Latina women. 

Published in Focus on Patient Care

Articles published today by UAB and its Geroscience Network collaborators explore new interventions in aging processes as part of an effort to increase the healthy, independent years of life for the elderly. 

The mechanism of widespread reorganization of DNA methylation may be a therapeutic target to prevent or reverse dyskinesia.
UAB now offers the largest cancer precision medicine clinical trial, NCI-MATCH, with customized treatments for patients based on genetics.
Published in Focus on Patient Care
Page 1 of 63
Back to Top